Open Access
ARTICLE
Effectiveness of Maximal Androgen Blockade (MAB): illusion or reality?
Hideyuki Akaza
Department of Urology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
Address correspondence to Dr. H. Akaza, Department of
Urology, Institute of Clinical Medicine, University of
Tsukuba, Tsukuba City, Ibaraki, Japan
Canadian Journal of Urology 2005, 12(Suppl.1), 77-80.
Abstract
Two decades have passed since the concept of Maximal
Androgen Blockade (MAB) was first applied to the
clinical treatment of prostate cancer. The theory is that
by cutting off the supply of androgen from the adrenal
gland, androgen blockade of the prostate could be made
more complete. However, to date the clinical benefit of
MAB has failed to live up to the theoretically expected
effect. Having said that, fundamental research and
clinical trials in recent years do indicate that the benefit
of MAB is not merely an illusion.
Keywords
advanced prostate cancer, hormone therapy, maximal androgen blockade, combined androgen blockade
Cite This Article
APA Style
Akaza, H. (2005). Effectiveness of Maximal Androgen Blockade (MAB): illusion or reality?. Canadian Journal of Urology, 12(Suppl.1), 77–80.
Vancouver Style
Akaza H. Effectiveness of Maximal Androgen Blockade (MAB): illusion or reality?. Can J Urology. 2005;12(Suppl.1):77–80.
IEEE Style
H. Akaza, “Effectiveness of Maximal Androgen Blockade (MAB): illusion or reality?,” Can. J. Urology, vol. 12, no. Suppl.1, pp. 77–80, 2005.
Copyright © 2005 The Canadian Journal of Urology.